Wise et al observed statistically insignificant but slightly higher proportion of ER+ breast cancer cases in the uterine leiomyoma group (51.9%, 600/1156) than in the leiomyoma-free group (47.5%, 532/1120) [14]. This evidence concerns the gene ESR1 and breast carcinoma.